chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around 8:00pm that night of the vaccine I had chills, body aches, nauseous and very tired. I was in bed for two days with a bad migraine. I took medicine and it didn't really help so my body fought it off naturally. I called my doctor on that Friday and he advised me that those symptoms were normal and to just drink plenty of fluids and get some rest. I finally started to feel better two days later and now I am back to my normal daily activities.
Mother reports temp of 104 with Motrin. Rash to head, neck, extremities and trunk. Rash and high temp developed 04/01/2004.
Worsening of Hashimoto's disease; Worsening of Hashimoto's disease; pancreatic insufficiency; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Apr2021 at 14:30 as dose 2, single (Lot number: Er8729) at the age of 57 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Pancreas insufficiency" (unspecified if ongoing); "Hashimoto's disease" (unspecified if ongoing). Concomitant medication (in two weeks) included: LEVOTHYROXINE. Past drug history included: Codeine, reaction: "Known allergies". Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EP8729, administration time: 02:00 PM, vaccine location: right arm), administration date: 24Mar2021, when the patient was 57-year-old, for COVID-19 Immunization. The following information was reported: AUTOIMMUNE THYROIDITIS (hospitalization, disability, medically significant, life threatening), CONDITION AGGRAVATED (hospitalization, disability, medically significant, life threatening) all with onset 14May2021 at 14:00, outcome "not recovered" and all described as "Worsening of Hashimoto's disease"; PANCREATIC FAILURE (hospitalization, disability, medically significant, life threatening) with onset 14May2021 at 14:00, outcome "not recovered", described as "pancreatic insufficiency". The patient was hospitalized for autoimmune thyroiditis, condition aggravated, pancreatic failure (hospitalization duration: 1 day. The events "worsening of hashimoto's disease" and "pancreatic insufficiency" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of autoimmune thyroiditis, condition aggravated, pancreatic failure, which included fluids. Clinical course: The vaccination facility was reported as the public health clinic. The patient had no other vaccine in four weeks. The patient had no covid prior vaccination and was not tested for covid post vaccination.
This spontaneous report was received from a 57 year old registered nurse (who is also a patient) regarding herself. The patient has Hashimoto's disease. The patient had a past reaction consisted of hives and swelling lymph nodes after taking LEVAQUIN. On an unknown date in 1998 (reported as 15 years ago) the patient was vaccinated with the first dose of (oka-merck) VARIVAX, (lot number, expiry date was not reported, route was subcutaneous). On 18-APR-2013 the patient was vaccinated with second dose of (oka-merck) VARIVAX, (lot number, expiry date was not reported, route was subcutaneous). Concomitant therapies included SYNTHYROID. On 18-APR-2013, the patient developed redness and swelling about the size of a half dollar at the injection site after receiving the second dose of (oka-merck) VARIVAX. The site was painful, hard and hot. She also developed flu like symptoms. She has gotten better now and only has a small lump on the injection site. She did not have any reaction when she received the first dose of (oka-merck) VARIVAX. She had to get the second dose since the recent test showed negative titer. The patient was treated with ADVIL and fluids. There were no laboratory tests performed. The outcome of the reported events were reported as recovering. The patient did not seek medical attention. Additional information has been requested.
had Parkinson's and my symptoms got worse; Full blown period with clotting/haven't had period since 18 years so now it's heavy; Headache; Acne/cramping/was very irritable/it was PMS; tremor; an itchy chest including nipples/itchy rash, not swollen but a rash on chest and nipples which were itchy; This is a spontaneous report from a contactable consumer (patient). This 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm right on 06Mar2021 14:45 (Batch/Lot Number: EL3302) as a single dose for COVID-19 immunization. Medical history included Parkinson's, hypothyroidism, aortic insufficiency, allergies: penicillin, tea tree oil, latex, whey. Patient is not pregnant at the time of vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID) taken for hypothyroidism from 1998 and ongoing, carbidopa, levodopa (CARBIDOPA LEVODOPA) taken for Parkinson's disease from Feb2013; and estradiol (VIVELLE DOT) for estrogen therapy. Patient previously took prochlorperazine edisylate (Compazine) and morphine and experienced allergies for both. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination. Patient has not had a period for 18 years. On 07Mar2021 12:00, patient got an itchy chest including nipples, irritability, acne and a heavy full blown period with clotting, cramping, etc. AE resulted in doctor or other healthcare professional office/clinic visit. Events were also reported as follows: patient experienced itchy rash, not swollen but a rash on chest and nipples which were itchy. Patient had Parkinson's and her symptoms got worse. She just went to her neurologist and thought that was a little strange and patient had headache. It was reported that she was irritable, it was PMS. Then patient had full blown period and patient have not had period since 18 years so now it was heavy. Patient had neurology appointment a short time ago and she was doing great and she also had her urology appointment on 23Feb2021 and everything was fine. Patient did use Vivelle-Dot which is half of a milligram, it is an estrogen therapy, but patient have never had any problems with bleeding at all, "nothing like that ever". Itching started on 06Mar2021, and then over the next couple of days, patient started having headaches, irritability, cramping, just overall Parkinson's symptoms, and tremor (medication wasn't controlling her tremor anymore). Patient has not recovered from the events.
Patient reported sensation of lip tingling 13 minutes after vaccine administration. Symptoms resolved with minutes after removing her mask and drinking water. Patient was observed for 30 minutes with no new or worsening symptoms. She remained well appearing throughout observation.
2/10/21 Headache started at 7pm and progressively got worse. Achy joints and muscles began at 9pm. At 11:30pm I was shaking in bed, low-grade fever, teeth-chattering, muscles tense, couldn't get comfortable. Got up to take Tylenol about 12am. Legs were weak, hands/arms shaking. Took two Tylenol and 4 Advil. Became more comfortable and last looked at the clock at 2am. Woke up with flu aches... Body aches, skin sensitivity. This lasted until 10-11pm on 2/11/21. Woke up 2/12/21 with no symptoms.
Case number PHEH2011US009548 is combined initial and follow-up spontaneous report received from nurse on 10 Nov 2011 and 14 Nov 2011 respectively: This case refers to a male patient of unknown age. Previously he was vaccinated with MENVEO and which was tolerated well. He was vaccinated MENVEO (batch number: M10051) intramuscularly on unspecified date. After vaccination he experienced syncope. The patient became normal within 5-10 minutes after syncope. The final event outcome and causality were not reported.
This spontaneous report was received from the patient's grandmother and refers to an unborn patient. The patient's mother was 20 year of age with no drug reactions or allergies. Her concurrent conditions included high cholesterol and fatigue and she was also a mononucleosis carrier. At the time of the report on 25-FEB-2016, the patient's mother was 30 weeks pregnant with LMP (last menstrual period) of 30-JUL-2015, EDD (estimated date of delivery) of 05-MAY-2016 and date of conception of 13-AUG-2015. The pregnancy outcome was pending. On 11-FEB-2016 (reported as "2 weeks ago"), the patient's mother had visited her physician for her 28-week examination. The physician advised, that she should take a "whooping cough vaccine". On an unknown date in February 2016, the patient's mother was erroneously vaccinated with a dose of GARDASIL (lot # was not provided) first injection, 0.5 ml, intramuscularly for prophylaxis instead of receiving a "whooping cough vaccine". Concomitant therapies included prenatal vitamins. The patient's mother sought medical attention and was given an ultrasound to check progress of the baby (patient) in uterus (results were not provided). Since an unknown date in February 2016 (reported as "since that time"), the patient's mother noted that the baby (patient) had "flipped" and felt less active. The outcome of the events was unknown. The relatedness between the events and GARDASIL was not reported. This is one of two reports received from the same source. Additional information has been requested. This is an amended report. The suspect therapy was corrected to GARDASIL. Sender's Comments: US-009507513-1602USA012213: MERCK 1603USA001784: Mfr number.
After the first dose, within a couple of days, purple patches started appearing randomly in my upper thorax, along my arms, across my chest,.  I thought this was a typical "rash", but they are not. They are not antihistamine responsive, have developed a scaly crust-like surface, resembling psoriasis.  On my face, I developed dry, scaling skin beneath both eyes and on the bridge of my nose.  None of these symptoms have diminished.  I had shot number 1 on March 2, and shot number 2 on March 23.  The purple splotches are as large as 1.25 inches in diameter, but most are smaller than that.  I am a registered pharmacist, and have never seen, nor experienced, anything like this. They itch, they are rough, like mild sandpaper, and they persist,  now going on for about a month.  I am hoping they resolve soon.
Instant dizziness, pain in the neck area, loss of arm motion, Violent shaking at night, fever 101.8. Body aches, headache, sensitivity to light, low grade fever for 48 hours. Felt slightly better taking Advil for 48 hrs.
Later afternoon - felt chills/feverish (or day of vaccine). Did not check temperature. Felt fatigued. At bedtime heart was racing like it did when he went into atrial flutter in June. Took 2 doses of PRN propranolol. At 4 AM 7/24 felt like went back into sinus rhythm.
Patient got dizzy and threw up immediately after receiving vaccine. Very pale. After drinking water and relaxing felt okay, Stayed for 15 minutes and still felt okay
Reported dizziness. No SOB.  At 1426: 136.89, HR 106 99% pulse ox.  Reported feeling fine at 30 minutes.
The vaccine that was given was expired. As of now there have been no s/s of any adverse events
This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (made an error by giving  a shot from a vile that had been punctured 19 hours prior) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (made an error by giving  a shot from a vile that had been punctured 19 hours prior). On 02-Nov-2021, EXPIRED PRODUCT ADMINISTERED (made an error by giving  a shot from a vile that had been punctured 19 hours prior) had resolved. Not Provided          No concomitant medications were provided.  No treatment information was provided by the reporter.
left leg seriously cramped up around 11pm  last night waking me out of sleep.  continues to feel worse it is 9:50am .   can barely move left leg
Note: she developed extremely painful red plaques near the injection site. The next day a second plaque appeared, without edema, just redness and pain. I treated these with prednisone 40mg a day for 2 days and they slowly disappeared.
Patient had COVID-19. Patient is fully vaccinated. Patient was hospitalized and is due home after kidney function tests. Patient also had a booster shot on 8/21/2021.
Bilateral arms, face flushed, reddened about 2 hours post receiving H1N1 shot. Patient was given vaccine at 12 noon. Given BENDARYL 25 mg p.o with relief. Denies exposure to any allergen.
Patient was previously vaccinated on 3.24.21 with Jansen COVID-19 vaccine. Lot 1808609 but did not report being previously vaccinated and received a second shot.
During the monitoring period, patient began complaining of a headache. Tylenol was offered and given, 1000mg po.  Patient was monitored an additional 30 minutes when he stated he was feeling better and was ready to leave.
FIRST THING WHEN GETTING UP IN THE MORNING, FELT DIZZY, NAUSEA AND VOMITED 3-4 TIMES, Increase in Blood Pressure; Treated with Phenergan for N & V; and rest, fluids.  Lasted just this day, but wasn't back to normal for 2 days.
3er dose at 6 month of age on April 4th 2022,  second dose was administered on February 23rd 2022; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 6-month-old patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Pediarix (1st dose of Pediarix received on 22nd December 2021). Concomitant products included PEDIARIX.   On 4th April 2022, the patient received the 3rd dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 4th April 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-APR-2022 Reporter's Comment: The reporter was medical assistant. The patient's identifiers and vaccine lot number was not gathered.  The Vaccine Administration Facility was the same as Primary Reporter. The reporter did not consent to follow-up. Additional Supportive Information: The reporter reported that the patient received the third dose of Pediarix earlier than the recommended interval, which led to shortening of vaccination schedule.
DIZZY; FELT SORTA HUNGOVER; CHILLS; SUPER NAUSEATED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced dizzy, sorta hungover, chills, and super nauseated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the super nauseated, dizzy, chills and sorta hungover was not reported. This report was non-serious.
slight fever; chills; Injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 27-Year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 24Feb2021at 03:30 PM as single dose for COVID-19 immunization. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 03Feb2021 at 03:30 PM as single dose for COVID-19 immunization. Medical history was not reported. Patient had no known allergies. Concomitant medications included vitamin d NOS, desogestrel, ethinylestradiol (APRI) as birth Control. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient was not pregnant at the time of vaccination. On 24Feb2021 at 09:00 PM (after second vaccine dose) patient experienced slight fever and chills about 5 hours after vaccination. The next day, fever and chills continued. Injection site soreness started a few hours after vaccination and has become quite. No treatment was received. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Information has been received from a registered nurse concerning an 18 year old female, who on 26-JUL-2007 was vaccinated with a first dose of Gardasil. On 26-JUL-2007 the patient passed out. It was reported that her pupils were dilated and she experienced a 10 second seizure. The patient sought unspecified medical attention. On 26-JUL-2007 the patient recovered. No product quality complaint was involved. Upon internal review, seizure was considered to be an other important medical event. Additional information has been requested.
rash; slight headache; 101 F Fever; chill; A spontaneous report was received from a consumer concerning a 66-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events 101 f fever, slight headache, rash, chills.  The patient's medical history was provided. penicillin for allergy.   Concomitant medications reported were baby aspirin , 10 VK penicillin, Atenolol, Bystolic, Simvastatin, generic Zyrtec for allergy , Pantoprazole , Valsartan , Hydrochlorothiazide, vitamins for drug use for unknown indication.  On 19 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 037K20A) via unknown route for prophylaxis of COVID-19 infection. On 16 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 006M20A) via unknown route for prophylaxis of COVID-19 infection.  On 17 Feb 2021, the patient experienced the events 101 f fever, slight headache. On 19 Feb 2021, the patient experienced the events rash, chills.  Treatment details included Tylenol and Benadryl.  Action taken with mRNA-1273 in response to the events was not applicable.  On 18 Feb 2021 the outcome of events, 101 f fever, slight headache, chills was resolved. The outcome of event(s), rash was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report was received from a nurse prescriber refers to multiple unspecified patients of unknown age. The patients' medical history, concomitant medication and concurrent conditions were not reported. On an unknown dates, the patients were vaccinated with improperly stored dose of PNEUMOVAX23 from lot # M018766 with expiry: 15-OCT-2017, for prophylaxis. No adverse effect reported. The vaccine was stored at 47° F to 77° F for 11 hours. It also had previous temperature excursion and the excursion was detected by digital data logger.
Extreme arthritis flare up and all major joints especially in the arms, hands, wrists, shoulders and hips are really inflamed; needed help to stand up and get out of my chair; This is a spontaneous report from a contactable consumer (patient).  A 61-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EW0164), via an unspecified route of administration in the right arm, on 16Apr2021 at 03:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis, ankylosing spondylitis, hereditary nephritis, penicillin allergy, and sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included pantoprazole (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), adalimumab (HUMIRA), and ibuprofen (MANUFACTURER UNKNOWN). The patient previously took tetracycline hydrochloride (MANUFACTURER UNKNOWN) and experienced allergy. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: ER8733) on 26Mar2021 at 02:00 (at the age of 61-years-old) in the left arm for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced extreme arthritis flare up and all major joints especially in the arms, hands, wrists, shoulders and hips are really inflamed and needed help to stand up and get out of my chair on 17Apr2021 at 04:00.  Therapeutic measures were taken as a result of the events, which included unspecified steroids. The clinical outcome of extreme arthritis flare up and all major joints especially in the arms, hands, wrists, shoulders and hips are really inflamed and needed help to stand up and get out of my chair was not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Within five minutes after administration of vaccination patient went completely limp and unresponsive. Was taken back into the doctor's office immediately to be examined.
Patient did not have an adverse reaction. Patient was given by mistake Kinrix Dtap for ages 4-6. Patient was suppose to receive pediarix vaccine bc of patients age. Patient was 10 months at the time the incident occurred. Contacted disease control and reached put to patient parents. Patient parents number they provided on epic chart are disconnected. Reported incident to disease control. Disease control stated using kinrix vaccine as an early dose is an administration error. However , if given by mistake as an early dose it may be counted as valid for both D-tap and polio and doesn't need to be repeated. When charting the vaccine before administration epic did not flag the vaccine.
Child (2mo) adm. expired dose of ROTATEQ on 12-30-10 per order of Dr. - parent to be called for redose of child 4-wks from previous dose on or after 1-30-11.
A month after the vaccine I would wake up at night and felt like heart was spinning. Later started to feel skipping heartbeat when walking up stairs. Went to doctor and confirmed that my heart was skipping beats, had an EKG done, but nothing concrete was found. Wore a heart monitor for 2 days, but had no results. Was sent to a Cardiologist and to have a Stress test and EKG they saw that I was a little poky in one of my heart chambers, but I didn't know which one. On 8/31/2022 saw another Cardiologist who deals with electrical side of the heart, he decided to have me wear a heart monitor that for a month. Saw unusual heartbeats but was still considered in the normal range. Was scheduled for a Nuclear Stress test, the results were normal. Eventually I stopped having the episodes of skipped heart beats. Heart seems to be back to normal.
PER DR-ENTIRELY WITHOUT SYMPTOMS WHEN RECEIVED FLUMIST.  RECEIVED FLUMIST 10/12/2009.  PM ON 10/13/2009 LETHARGY AND TEMP 100.8.  10/14/2009 TEMP 101.2-TO SEE DR IF TEMP IN 2 DAYS OR BEFORE IF SYMPTOMS WORSEN.
3" HOT red rash at injection site -- ie, hot to touch.  Swollen 6" diameter at injection site growing to swollen entire upper arm.  Fatigue.  Headache + low-grade fever.   Treatment: fluids, ibuprofen, removal from school, rest.